Article Text

Download PDFPDF
Spironolactone of no benefit in people with AF and HFpEF


Overview of: Shantsila E, Shahid F, Sun Y, et al. Spironolactone to improve exercise tolerance in people with permanent atrial fibrillation and preserved ejection fraction: the IMPRESS-AF RCT. Efficacy Mech Eval 2020; 7(4).

  • drug-related side effects and adverse reactions
  • health care quality
  • access
  • and evaluation

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.


  • Contributors DTB Team.

  • Provenance and peer review Commissioned; internally peer reviewed.